[#item_full_content]
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint Data to NUBEQA® (darolutamide) Prescribing Information
Footer
We want our generation to succeed and not fall victim to the daunting statistics.
We want our generation to succeed and not fall victim to the daunting statistics.
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish